In patients with non-Hodgkin's lymphoma, researchers have found a way to turn cells in the patients' own immune system into cancer-fighting machines. In a new study, researchers injected patients with a drug that helped immune cells attach themselves to tumor cells. The study saw considerable improvement in only 11 of the 38 patients in this preliminary trial, but researchers say the results are significant because all seven of the patients who received the highest dose of medication saw their tumors shrink. In four cases, the tumors completely vanished. The new results are the latest promising finding in the developing field of immunotherapy, in which the body's own defenses are augmented and then unleashed to fight back disease. Researchers are also investigating ways to train the immune system to attack brain cancer tumors, and in June
doctors announced that a patient with advanced skin cancer was free of the disease two ...
